Dupont Capital Management Corp Lantheus Holdings, Inc. Transaction History

Dupont Capital Management Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 25, 2023	SELL	$82.41 - $99.65 $12,279 - $14,847	-149 Reduced 10.25%	1,304 $109,000
Q1 2023 Apr 28, 2023	SELL	$47.76 - $82.86 $13,181 - $22,869	-276 Reduced 15.96%	1,453 $119,000
Q4 2022 Jan 26, 2023	SELL	$48.76 - $77.67 $248,773 - $396,272	-5,102 Reduced 74.69%	1,729 $0
Q3 2022 Oct 31, 2022	BUY	$61.42 - $86.29 $389,894 - $547,768	6,348 Added 1314.29%	6,831 $480,000
Q2 2022 Jul 26, 2022	BUY	$55.54 - $72.65 $26,825 - $35,089	483 New	483 $32,000
Q1 2020 Apr 29, 2020	SELL	$9.11 - $20.05 $223,058 - $490,924	-24,485 Closed	0 $0
Q3 2019 Oct 28, 2019	SELL	$21.01 - $28.94 $438,184 - $603,572	-20,856 Reduced 46.0%	24,485 $614,000
Q2 2019 Jul 30, 2019	BUY	$23.33 - $28.3 $698,290 - $847,047	29,931 Added 194.23%	45,341 $1.28 Million
Q1 2019 Apr 30, 2019	BUY	$14.93 - $25.1 $230,071 - $386,791	15,410 New	15,410 $377,000

542

77.9M

710K

433K

Ticker LNTH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 68,741,904
Market Cap $3.62B
Description
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for n...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.